Exploring Immune Cell Signatures in Autoimmunity and Dry Eye Syndrome
Exploring Immune Cell Signatures in Autoimmunity and Ocular Surface Stress
Sponsor: SingHealth Translational Immunology and Inflammation Centre
Listed as NCT02715323, this observational or N/A phase trial focuses on Autoimmunity and Dry Eye Syndrome and remains completed. Sponsored by SingHealth Translational Immunology and Inflammation Centre, it has been updated 11 times since 2016, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
11 versions recorded-
Sep 2024 — Present [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
May 2024 — Jul 2024 [monthly]
Completed
Status: Recruiting → Completed
-
Apr 2023 — May 2024 [monthly]
Recruiting
-
Apr 2022 — Apr 2023 [monthly]
Recruiting
▶ Show 6 earlier versions
-
Jan 2021 — Apr 2022 [monthly]
Recruiting
-
Nov 2020 — Jan 2021 [monthly]
Recruiting
-
Jun 2019 — Nov 2020 [monthly]
Recruiting
-
Jun 2018 — Jun 2019 [monthly]
Recruiting
-
Apr 2018 — Jun 2018 [monthly]
Recruiting
Phase: NA → None
-
Jan 2017 — Apr 2018 [monthly]
Recruiting NA
First recorded
May 2016
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- SingHealth Translational Immunology and Inflammation Centre
- Singapore National Eye Centre
- TTSH Eye Clinic
For direct contact, visit the study record on ClinicalTrials.gov .